Chenwei Yuan

671 total citations
21 papers, 471 citations indexed

About

Chenwei Yuan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chenwei Yuan has authored 21 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Chenwei Yuan's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Chenwei Yuan is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (4 papers) and Circular RNAs in diseases (4 papers). Chenwei Yuan collaborates with scholars based in China, Germany and Hong Kong. Chenwei Yuan's co-authors include Jinsong Lu, Liheng Zhou, Shuguang Xu, Wenjin Yin, Yanping Lin, Jing Peng, Zhihai Peng, Chenchen Liu, Yaqian Xu and Xiaonan Sheng and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Chenwei Yuan

20 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenwei Yuan China 12 306 268 120 77 41 21 471
Mincong Wang China 13 323 1.1× 200 0.7× 67 0.6× 99 1.3× 74 1.8× 25 478
Xianghong Yang China 11 315 1.0× 188 0.7× 102 0.8× 96 1.2× 65 1.6× 21 520
Yuan Lu China 13 360 1.2× 291 1.1× 44 0.4× 59 0.8× 24 0.6× 26 491
Wenyan Ren China 10 434 1.4× 324 1.2× 263 2.2× 57 0.7× 40 1.0× 15 604
Feng Luo China 11 188 0.6× 159 0.6× 169 1.4× 58 0.8× 25 0.6× 20 390
Qunhui Wang China 11 217 0.7× 148 0.6× 152 1.3× 75 1.0× 30 0.7× 42 390
Xian-Ying Zhu China 7 340 1.1× 249 0.9× 357 3.0× 67 0.9× 37 0.9× 14 567
Weimin Ren China 15 317 1.0× 244 0.9× 75 0.6× 105 1.4× 27 0.7× 23 543
Jungang Zhao China 11 278 0.9× 218 0.8× 130 1.1× 60 0.8× 26 0.6× 23 407

Countries citing papers authored by Chenwei Yuan

Since Specialization
Citations

This map shows the geographic impact of Chenwei Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenwei Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenwei Yuan more than expected).

Fields of papers citing papers by Chenwei Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenwei Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenwei Yuan. The network helps show where Chenwei Yuan may publish in the future.

Co-authorship network of co-authors of Chenwei Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Chenwei Yuan. A scholar is included among the top collaborators of Chenwei Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenwei Yuan. Chenwei Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalangood, Sumiya, Cegui Hu, Chenwei Yuan, et al.. (2025). Cancer-associated adipocytes mediate CD8+T cell dysfunction via FGF21-driven lipolysis. Cell Reports. 44(11). 116526–116526.
2.
Yuan, Chenwei, Yaqian Xu, Liheng Zhou, et al.. (2024). Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohort. European journal of medical research. 29(1). 454–454. 1 indexed citations
3.
Yuan, Chenwei, Jingjing Lu, Yue Jiang, et al.. (2024). Influence of tunnel excavation on the magnitude and rotation angle of principal stress in surrounding rock. Scientific Reports. 14(1). 25512–25512. 2 indexed citations
4.
Peng, Jing, Xiaonan Sheng, Chenwei Yuan, et al.. (2024). Serum miRNA-1 may serve as a promising noninvasive biomarker for predicting treatment response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer. 24(1). 789–789. 4 indexed citations
5.
Yuan, Chenwei, Xiaohan Wu, Fei He, et al.. (2024). Co-exposure of polystyrene nanoplastics and copper induces development toxicity and intestinal mitochondrial dysfunction in vivo and in vitro. The Science of The Total Environment. 930. 172681–172681. 14 indexed citations
6.
Qiao, Wen, Cegui Hu, Jiayi Ma, et al.. (2023). Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity. Cancer Letters. 573. 216370–216370. 6 indexed citations
7.
Sha, Rui, Ziping Wu, Yaqian Xu, et al.. (2021). Predictive value of lncRNA LOC100505851 in breast cancer in the neoadjuvant setting. Gland Surgery. 10(6). 1899–1909. 2 indexed citations
8.
Xu, Yaqian, Chenwei Yuan, Jing Peng, et al.. (2021). LncRNA MIR205HG expression predicts efficacy of neoadjuvant chemotherapy for patients with locally advanced breast cancer. Genes & Diseases. 9(4). 837–840. 6 indexed citations
9.
Sha, Rui, Yaqian Xu, Chenwei Yuan, et al.. (2021). Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapy. EBioMedicine. 71. 103560–103560. 119 indexed citations
10.
11.
Zhang, Lei, Chenwei Yuan, Jing Peng, et al.. (2020). SHP-2-Mediated Upregulation of ZEB1 Is Important for PDGF-B-Induced Cell Proliferation and Metastatic Phenotype in Triple Negative Breast Cancer. Frontiers in Oncology. 10. 1230–1230. 11 indexed citations
12.
Xu, Yaqian, Yan Wang, Chenwei Yuan, et al.. (2020). Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy. Therapeutic Advances in Medical Oncology. 12. 3863555926–3863555926. 5 indexed citations
13.
Zhang, Lei, Yueyao Du, Shuguang Xu, et al.. (2018). DEPDC1, negatively regulated by miR-26b, facilitates cell proliferation via the up-regulation of FOXM1 expression in TNBC. Cancer Letters. 442. 242–251. 50 indexed citations
14.
Yuan, Chenwei, Liheng Zhou, Lei Zhang, et al.. (2018). Identification and Integrated Analysis of Key Differentially Expressed Circular RNAs in ER-Positive Subtype Breast Cancer. Epigenomics. 11(3). 297–321. 31 indexed citations
15.
Peng, Jing, Lei Zhang, Chenwei Yuan, et al.. (2017). Expression profile analysis of long noncoding RNA in ER-positive subtype breast cancer using microarray technique and bioinformatics. Cancer Management and Research. Volume 9. 891–901. 22 indexed citations
16.
Huang, Guoyu, Jun Cheng, Fudong Yu, et al.. (2016). Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer. Oncology Reports. 35(5). 2801–2810. 38 indexed citations
17.
Yuan, Chenwei, Xingwu Zhu, Han Yang, et al.. (2016). Elevated HOXA1 expression correlates with accelerated tumor cell proliferation and poor prognosis in gastric cancer partly via cyclin D1. Journal of Experimental & Clinical Cancer Research. 35(1). 15–15. 59 indexed citations
18.
Lin, Shengtao, Tao Jiang, Ling Ye, et al.. (2016). The chromatin-remodeling enzyme BRG1 promotes colon cancer progression via positive regulation of WNT3A. Oncotarget. 7(52). 86051–86063. 23 indexed citations
19.
Liu, Chenchen, Ben Yue, Chenwei Yuan, et al.. (2015). Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancer. Biochemical and Biophysical Research Communications. 468(1-2). 53–58. 13 indexed citations
20.
Zhu, Xingwu, Han Yang, Chenwei Yuan, et al.. (2014). Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer. Oncology Reports. 33(1). 320–328. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mincong Wang Breakdown of academic impact, for papers by Xianghong Yang Breakdown of academic impact, for papers by Yuan Lu Breakdown of academic impact, for papers by Wenyan Ren Breakdown of academic impact, for papers by Feng Luo Breakdown of academic impact, for papers by Qunhui Wang Breakdown of academic impact, for papers by Xian-Ying Zhu Breakdown of academic impact, for papers by Weimin Ren Breakdown of academic impact, for papers by Jungang Zhao
Rankless by CCL
2026